Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus-infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%...
Saved in:
Main Authors: | Aurpibul L., Puthanakit T., Sirisanthana T., Sirisanthana V. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-77951814475&partnerID=40&md5=2f0ea52adec1111a9724c5f9c093fa12 http://www.ncbi.nlm.nih.gov/pubmed/20377409 http://cmuir.cmu.ac.th/handle/6653943832/2581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018) -
Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Aurpibul L., et al.
Published: (2014) -
Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
by: Linda Aurpibul, et al.
Published: (2018) -
Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy
by: Lao-araya M., et al.
Published: (2014) -
Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy
by: Mongkol Lao-araya, et al.
Published: (2018)